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SUMMARY
The hematopoietic stem cell (HSC) compartment consists of a small pool of cells capable of replenishing all blood cells. Although it is
established that the hematopoietic system is assembled as a hierarchical organization under steady-state conditions, emerging evidence
suggests that distinct differentiation pathways may exist in response to acute stress. However, it remains unclear how different hemato-
poietic stem and progenitor cell subpopulations behave under sustained chronic stress. Here, by using adult transgenicmice overexpress-
ing erythropoietin (EPO; Tg6) and a combination of in vivo, in vitro, and deep-sequencing approaches, we found that HSCs respond differ-
entially to chronic erythroid stress comparedwith their closely relatedmultipotent progenitors (MPPs). Specifically, HSCs exhibit a vastly
committed erythroid progenitor profile with enhanced cell division, while MPPs display erythroid and myeloid cell signatures and an
accumulation of uncommitted cells. Thus, our results identify HSCs as master regulators of chronic stress erythropoiesis, potentially
circumventing the hierarchical differentiation-detour.
INTRODUCTION
All lineages of hematopoietic cells, including those of the
erythroid lineage, arise from a unique population of he-
matopoietic stemcells (HSCs) (Clapes et al., 2016).However,
whether all mature blood cells are derived from these HSCs
or fromdownstreammultipotentprogenitors (MPPs)during
steady-state hematopoiesis remains contentious (Busch
et al., 2015; Sawai et al., 2016; Sun et al., 2014). Previous
work in thefieldofHSCbiologyhasmainly focusedonacute
stress, including bone marrow (BM) injury or infection
(Haas et al., 2015), which typically triggers an increase of
HSCs that enter the cell cycle; HSCs return to quiescence
when homeostasis is re-established (Baldridge et al., 2010;
Trumpp et al., 2010). Interestingly, a number of studies
have also suggested that HSCs and MPPs can circumvent
these distinct intermediate stages (Haas et al., 2015; Pietras
et al., 2015; Sanjuan-Pla et al., 2013; Yamamoto et al., 2013).
Recently, attention is being drawn to the chronic effects
of emergency signals (such as interleukin-1 [IL-1]), their
impact on the immune system, and their long-term conse-
quences on the HSC compartment (Pietras et al., 2016).
However, much remains to be understood regarding how
chronic overexpression of lineage-specific proteins such
as erythropoietin (EPO) may influence HSC/MPP fate.
The latter hormone is the principal stimulator of erythro-
poiesis, a complex multistep process during which
erythroid progenitors develop into mature red blood cells
(RBCs). EPO binding to its receptor (EPO-R) activates mul-
tiple pathways, including the JAK/STAT and the MAPK-
ERK1/2 pathways, which reduce apoptosis and promote
expansion and differentiation of erythroid progenitors
(Dunlop et al., 2006; Franke et al., 2013a; Gassmann and
Muckenthaler, 2015). Increased EPO production resulting
frommutations in specific members of the hypoxia-induc-
ible factor (HIF) pathway (e.g., VHL, HIF2a, or PHD2) may
lead to secondary erythrocytosis, representing the aberrant
increase in RBC numbers (Franke et al., 2013b). In this
report, using the well-defined EPO transgenic mouse line
(Tg6) (Ruschitzka et al., 2000), we establish that HSCs
and MPPs respond differently to chronic and sustained
erythroid stress. Specifically, HSCs display a substantial
erythroid progenitor profile in a quest to differentiate
into erythrocytes potentially bypassing numerous down-
stream progenitors, while MPPs limit their internal
commitment toward myeloid progenitors.
RESULTS
To understand the role of chronic and sustained erythroid
stress on the entire hematopoietic compartment, we used
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the well-defined EPO transgenic mouse line (Tg6). Inde-
pendent of the oxygen conditions, these mice constitu-
tively show high serum levels of human EPO, resulting in
excessive production of RBCs (Figure S1A) (Ruschitzka
et al., 2000). The bipotent pre-megakaryocyte erythrocyte
progenitor (Pre-MgE), which is upstream of the more
committed erythroid-restricted progenitor (Pre-CFUe), the
CFUe (colony-forming unit erythroid) and erythroblasts
(EBs), have been suggested as the first cells in the hemato-
poietic tree to robustly express EPO-R during hematopoie-
sis in humans (Seita et al., 2012). Although Tg6 mice did
not display any alteration in Pre-MgE as compared with
wild-type (WT) mice, the relative proportions of Pre-
CFUe, but not CFUe, were significantly higher in Tg6
mice. Conversely, megakaryocyte progenitors (MkP) and
pre-granulocyte-monocyte lineage cells (Pre-GM) were
significantly reduced (Figures 1A, 1B, and S1B; gating
according to Pronk et al., 2007). Furthermore, compared
with Pre-CFUe, Tg6 CFUe’s were progressing significantly
more through the cell cycle comparedwithWTCFUe’s (Fig-
ures 1C and 1D), strongly indicating a prominent prolifer-
ation/differentiation impulse toward downstream EBs (Fig-
ures 1E and S1C; gating according to Dumitriu et al., 2010)
and RBCs (Figure S1A). Upstream of Pre-GM, common
myeloid progenitors (CMPs) were also reduced in Tg6 BM
cells (Figures 1F and S1D; gating according to Akashi
et al., 2000).We next analyzed the HSC/MPP compartment
immediately upstream of the CMPs, which consists of a
heterogeneous population. Interestingly, although the
HSC fraction (CD48–/CD150+ Lineage SCA-1+ Kit+ [LSK]
(= LT-HSC and MPP1 [Wilson et al., 2008]) displayed a
significant increase in absolute numbers but not in its
relative abundance, the MPP population (CD48+/CD150–
LSK cells (= MPP3 and MPP4 [Wilson et al., 2008]) was
both relatively and absolutely expanded more than
2-fold, compared with WT littermates (Figures 2A and
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Figure 1. Sustained Chronic Exposure to High Systemic EPO Levels Leads to Dramatic Changes in Myeloid/Erythroid Progenitor
(A) Gating strategy for the myeloid-erythroid-megakaryocyte progenitors gated on Lin SCA-1 cKIT+ CD41 CD16/32– according to Pronk
et al. (2007).
(B) Bar graphs showing Pre-MgE (Lin SCA-1– cKIT+ CD41– CD16/32– CD105– CD150+), Pre-CFUe (LinSCA-1– cKIT+ CD41– CD16/32– CD105+
CD150+), CFUe (Lin SCA-1– cKIT+ CD41– CD16/32– CD105+ CD150–), MkP (Lin SCA-1– cKIT+ CD41+ CD16/32– CD150+), and Pre-GM (Lin
SCA-1– cKIT+ CD41– CD16/32– CD105– CD150–) (n = 5–6), and one of three representative experiments is shown.
(C and D) Cell-cycle analysis of Pre-CFUe (C) and CFUe cells fromWT and Tg6 mice (D). Bar graphs representing the fraction of progenitors in
the quiescent G0 phase of the cell cycle (left) and progressing through the cell cycle (non-G0, right) (n = 4). Gating strategy for cell-cycle
analysis of cells is as shown in Figure S2A for HSC and MPP.
(E and F) EB (CD71+ Ter119+) (n = 4) (E) and CMP (Lin SCA-1– cKIT+ CD34+ CD16/32–) (n = 5–6) (F).
(C–F) Data are representative for two to three independent experiments. n denotes individual mice. Values are mean ± SEM. *p < 0.05.
See also Figure S1.
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2B). Together, these observations suggest a long-term surge
in erythroid progenitor populations at the expense of
myeloid progenitors, starting with CMP (Figure 2C).
To understand this differential response between HSCs
and MPPs, and the reduction in downstream myeloid pro-
genitors, we studied cell-cycle progression in the hemato-
poietic stem and progenitor cell (HSPC) compartment. To
this end, we found that a significantly higher number of
Tg6 HSCs progressed through the cell cycle compared
withWT HSCs. In contrast, Tg6MPPs were more quiescent
compared with their WT counterparts (Figures S2A and
2D). As the latter displays an apparent discrepancy with
the increase in total MPP numbers, we decided to define
the telomere lengths in MPPs from Tg6 and WT mice, as
these are a measure of the number of times a (stem) cell
has divided over time (Chiu et al., 1996). Our analyses
revealed significantly shorter telomeres in Tg6 MPPs than
in WT MPPs, which suggests longer overall survival and
subdued differentiation (less downstream progenitors) of
Tg6 MPPs, despite reduced instant proliferation. Further-
more, we also examined MPPs in 4-week-old mice and
found a clear trend toward lower numbers of Tg6 MPPs
compared with WT littermates (Figure S2B). Conversely,
we found no increased cycling of Tg6 MPPs in these
4-week-old mice (Figure S2C), although MPP cell numbers
in 6-week-old animals were no longer different (Figure S2B)
and further reverted in adult mice (Figure 2B). This further
supports the notion that, already at an early stage, Tg6
MPPs showmore preference to self-renew than to differen-
tiate in comparison with WT MPPs.
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Figure 2. Tg6 Mice Display an Increased HSC/MPP Compartment
(A) Gating strategy and representative fluorescence-activated cell sorting (FACS) plots of hematopoietic stem progenitor cell populations.
(B) Proportion and total HSC and MPP numbers fromWT and Tg6 mice (n = 5–7), one of more than five representative experiments is shown.
(C) The overall effect of chronic and continuous high EPO exposure on the classical representation of the hematopoietic tree taken from
data presented in Figures 1, 2, and S1.
(D) Bar graphs representing the fraction of HSCs and MPPs in the quiescent G0 phase of the cell cycle (left) and progressing through the cell
cycle (non-G0, right), (n = 15–17), from four independent experiments. Gating strategy as shown in Figure S2A.
(E) Relative telomere length of isolated MPPs from both genotypes (n = 5–6). Values are mean ± SEM. *p < 0.05.
See also Figure S2.
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To unravel the differential response of HSCs andMPPs to
chronic and sustained EPO exposure, we performed a
global transcriptome analysis, which uncovered a strong
divergence between hematopoietic progenitor populations
from Tg6 and WT mice (Figures 3A and S3A). Specifically,
HSCs from Tg6 and WT mice revealed more than 6,600
significantly differentially expressed genes (DEGs), while
that for MPPs was about 3,800 DEGs (Figures 3A and
S3B). Ontology analyses of genes that were at least 2-fold
upregulated in the HSCs and MPPs of Tg6 mice (Huang
da et al., 2009) indicated that HSCs from Tg6 mice were
significantly enriched in genes directly related to RBC pro-
duction (Figure 3B). These included transcripts involved in
erythrocyte structure (Dmtn, Epb4.1, and 4.2), heme
biosynthesis (e.g., all eight core members, namely Alas2,
Alad, Cpox, Fech, Hmbs, Uros, Urod, and Ppox [Nilsson
et al., 2009]), as well as a set of transcription factors directly
related to erythropoiesis, including Gata1, E2F4, Klf1, and
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Figure 3. Sustained and Chronic High EPO Induces Erythroid Transcriptional Reprograming in HSCs
(A) Schematic overview of the transcriptome sequencing setup to compare HSCs/MPPs from Tg6 and WT littermates (three samples per
genotype, and each sample contained cells from three individual mice).
(B) Adapted networks of the highest represented GO terms of genes withR2-fold overexpression in Tg6 HSCs versus WT littermate HSCs.
(C) Heatmaps depicting all genes from the HSC GO terms represented in (B).
(D) Immunofluorescent staining of the GATA1 transcription factor in sorted LT-HSC and MPP1 isolated from adult WT and Tg6 mice. Scale
bars represent 25 mm. GATA1 expression in sorted single cells defined by fluorescent intensity per cell. Data are representative for two
independent experiments. Representation of GATA1-prefered sites are shown in Figure S3C. Values are mean ± SEM. *p < 0.05.
See also Figures S3 and S4 and Table S1.
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Sox6 (Figures 3B and 3C) (Dumitriu et al., 2010; Gutierrez
et al., 2008; Humbert et al., 2000; Shah et al., 2015). Parallel
to these findings and our initial observations in Tg6 HSCs,
numerous gene ontology (GO) terms related to the ‘‘cell-cy-
cle process’’ were uncovered, which corresponded to more
than 100 Tg6 HSCs genes (R2-fold) significantly overex-
pressed in the diverse phases of the division process (Fig-
ures 3B and 3C).
To support these results, we performed immunofluores-
cent staining for GATA1 on sorted cells. We stained LT-HSC
and MPP1 separately (CD34– and CD34+ HSCs, respec-
tively) as it was shown previously that the latter population
can give rise to stress erythroid progenitors (Harandi et al.,
2010). Interestingly, both Tg6 fractions showed a signifi-
cant increase in GATA1 staining compared with their
respective WT control cells (Figure 3D). Further, we found
an increase in all target genes with ‘‘GATA1-prefered sites’’
that contribute to erythroid differentiation (Figure S3C)
(Suzuki et al., 2013), and a significant downregulation of
Gata2 (Figure S3D), an HSC-specific transcription factor
that is directly and transcriptionally repressed, and physi-
cally replaced from chromatin, by GATA1 (Bresnick et al.,
2010).
In stark contrast with RNA sequencing (RNA-seq) data
from HSPCs after acute exposure to high EPO (Grover
et al., 2014), the Tg6 MPPs displayed GO terms that are
positively associated with the innate immune system (Fig-
ure 4A). Moreover, a large set of myeloid lineage markers
such as mst1r (macrophage-stimulating protein 1 receptor),
Tlr1 (Toll-like receptor 1), Cebpb (CCAAT/enhancer-binding
protein beta), and Csf1r (macrophage colony-stimulating factor
1 receptor) were highly upregulated, with only a less-pro-
nounced link toward erythropoiesis, especially in compar-
isonwith the erythroid genes induced in Tg6HSCs (Figures
4B and S4A). CSF1R is a receptor for the macrophage
colony-stimulating factor, and is known to influence
HSPC differentiation into monocytes/macrophages (Stan-
ley and Chitu, 2014). Consistently, we also demonstrate
that a significantly higher fraction of Tg6 MPPs display
CSF1R on their surface (Figure 4C); this is, however,
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Figure 4. Sustained and Chronic High EPO Induces a Dual Signature in MPPs
(A) Adapted networks of the highest represented GO terms of genes withR2-fold overexpression in Tg6 MPPs versus WT littermate MPPs.
(B) Heatmaps depicting all genes from the MPP GO terms represented in (A).
(C) Proportion of CSF1R+ cells in Tg6 versus WT MPPs.
(D) GATA1 expression in sorted single cells defined by fluorescent intensity per cell.
Data in (C) and (D) are representative for two independent experiments. Values are mean ± SEM. *p < 0.05.
See also Figure S4 and Table S2.
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independent of a potential increase in the myeloid-biased
MPP3 cell population, as their relative percentages re-
mained comparable between Tg6 and WT mice (Fig-
ure S4B). In addition, we found no difference in GATA1
staining between both genotypes in a majority of their
MPPs (CSF1R), although CSF1R+ Tg6 MPPs contained
significantly less GATA1 than their control littermates
(Figure 4D).
To better define EPO-induced alterations in HSCs and
MPPs, we used published profile data on committed pro-
genitors (Li et al., 2014; Sanjuan-Pla et al., 2013); specif-
ically, we evaluated the gene signatures of various lineages
using gene set enrichment analysis (GSEA) (Mootha et al.,
2003; Subramanian et al., 2005). GSEA revealed that both
stem cells and progenitors from Tg6mice displayedmatch-
ing Pre-CFUe signatures, which contrasted with the strong
negative signature for the MkP gene set (Figure 5A). Down-
streamof thePre-CFUe,HSCs andMPPs exhibited apositive
signature for transcripts known to be upregulated in CFUe
cells (CFUe Up). Remarkably, the Tg6 MPP fraction also
contained a large set of significantly induced genes that,
according to CFUe signature, are expected to be downregu-
lated (normalized enrichment scores [NES]: +3.03; CFUe
down) (Li et al., 2014), while Tg6 HSCs showed an antici-
pated negative correlation for the same gene set (NES:
2.98). Interestingly, analysis of a set of 50 upregulated
genes in MPPs (from 65 genes that were significantly
changed and correlated with the CFUe down signature),
Figure 5. Tg6 HSCs Have a Clear Erythroid Signature, while the MPP Fraction Displays Two Different Signatures
(A) GSEA of significantly upregulated genes from Tg6 HSCs and MPPs compared with sets of genes from different erythroid/myeloid/
megakaryocyte progenitors, as shown in Figure 2C. Signs in the upper corner of the tables (+, –, = ) designate correlation of the signature
with respective progenitor (HSC/left, MPP/right) based on p value. Both signs underneath the CFUe tables reflect the potential
subsequent effect of the ‘‘up’’ or ‘‘down’’ signatures (><, opposing). p value as indicated (if p = 0.000, then p < 0.0001).
(B) Heatmap depicting all 65 significantly changed Tg6 MPP genes represented in the CFUe down signature (GSEA).
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showed a highly significant association with monocytes,
while the majority of the downregulated genes correlated
with B lymphocytes (Enrichr/Jensen TISSUES analysis; Fig-
ure 5B) (Kuleshov et al., 2016; Lachmann et al., 2010).
Further, we compared significantly modulated Tg6 tran-
scripts with a set of Pre-GM genes, but were able to confirm
a highly significant and positive correlation with only Tg6
MPPs (Figure 5A). Together, these analyses clearly reveal
that Tg6 HSCs display an exclusive erythroid signature,
whereas the Tg6 MPP population exhibited erythroid as
well as myeloid signatures.
As our RNA-seq data revealed a significant 2-fold induc-
tion of Epo-R mRNA in Tg6 HSCs, we sought to assess the
in vivo activation of the JAK/STAT and the MAPK-ERK1/2
pathways in both HSCs and MPPs using mass cytometry
(Cytof). As expected, Tg6 CFUe cells showed significantly
more phosphorylation of STAT5 compared with WT cells
(Figure 6A); however, EPO/EPO-R pathwayswere not differ-
entially activated in Tg6 HSCs, MPPs, or Pre-MgE cells (Fig-
ures 6A, S5A, and S5B). Subsequently, we performed a semi-
solid colony-forming assay (no added EPO) using sorted
HSCs andMPPs from both Tg6 andWTmice to understand
the presence and extent of fate changes. In concurrence
with our in vivo and deep-sequencing data, Tg6 HSCs
yielded significantly higher erythroid progenitors (BFUe),
while Tg6 MPPs exhibited a lower differentiation potential
toward granulocyte/monocyte precursors (GM-CFU) (Fig-
ure 6B). In addition, we also defined the differentiation
potential of MPP2 (CD48+/CD150+ LSK cells), positioned
between HSC and MPP, with clear erythroid potential (Pie-
tras et al., 2015). We reveal significantly more MPP2 in the
BM of Tg6 mice, although without increase in cell-cycle
progression (Figures S5C and S5D). Moreover, and in clear
contrast to HSC or MPP, MPP2 showed no change in their
differentiation potential to any of the observed progenitors
(Figure S5E). These findings primarily show that the
enhanced differentiation of Tg6 HSC to BFUe is indepen-
dent of direct EPO signaling, and suggest that Tg6 HSCs
A
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Figure 6. Differential Tg6 HSCs Display a Clear Erythroid Signature, while the MPP Fraction Has Two Opposing Signatures
(A)Mass cytometry to quantify the phosphorylated forms of STAT5 in freshly isolated CFUe’s, HSCs, andMPPs fromWT and Tg6mice (n = 3–5).
(B) Bar graphs representing the number of colonies in the semi-solid ex vivo assay using HSCs or MPPs from both genotypes (n = 8).
(C and D) Transplantation assay in irradiated WT mice as depicted in Figure S5F. All mice were bled at the time points shown in (C) and (D)
and peripheral blood chimerism was defined by FACS (n = 4–5). Data are representative for two to three independent experiments. All
values are mean ± SEM. *p < 0.05.
See also Figure S5.
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do not necessarily have to differentiate into MPPs (e.g.,
MPP2 or 3) to become erythroid progenitors. Furthermore,
we examined the in vivo repopulation capacity of Tg6 HSCs
and MPPs (Figure S5F), and demonstrated that Tg6 HSCs
were able to produce significantly higher fractions of
RBCs compared with WT HSCs at 4 weeks after transplan-
tation, and that chimerism in RBCs and polymorphonu-
clear (PMN) cells was not significantly different between
the two donor groups at 16 weeks (Figure 6C). Tg6 MPPs,
on the other hand, lost their PMN differentiation potential
more rapidly than WT MPPs (Figure 6D), confirming our
initial findings (Figures 2C and 6B). Taken together, these
results strongly suggest that chronic exposure to excessive
EPO leads to differential fate changes in HSCs and MPPs.
DISCUSSION
In the current study, we used the EPO transgenic mouse
line Tg6 and a combination of in vivo, in vitro, and deep-
sequencing approaches to study the effects of chronic
EPO stress on HSCs and their closest progenitors, the
MPPs. We show that HSCs and MPPs display a clear differ-
ential response to such sustained stress. HSCs exhibit a
committed erythroid progenitor profile with enhanced
cell division and differentiation activity, while MPPs
display opposing cell signatures and an accumulation of
uncommitted cells.
Acute but short exposure of HSCs/MPPs to high EPO
levels has been shown to result in the creation of an
‘‘erythroid superhighway’’ that generates erythroid progen-
itors via the classical intermediates (Grover et al., 2014);
however, we show striking differences between HSC and
MPP lineages in mice chronically exposed to high EPO.
Essentially, while Tg6HSCs showed enhanced proliferation
with an induction of numerous cell-cycle-related genes,
Tg6 MPPs remained more quiescent and displayed
restrained differentiation. This highlights the differential
response of both cell populations and strongly points to
differentiation/proliferation of HSCs into erythroid pro-
genitors in an environment of sustained exposure to high
EPO. Further, although both Tg6 HSCs and MPPs showed
a clear erythroid signature, only HSCs displayed a promi-
nent increase in erythroid-related transcription factors
and a 5-fold induction in Klf1, one of the genes with a
GATA1-preferred site, which is regulated by it (Suzuki
et al., 2013). Conversely, Klf1 is even slightly downregu-
lated in Tg6 MPPs (1.4-fold). Since this transcription factor
was shown to stabilize GATA1’s occupancy in the b-globin
locus (Kang et al., 2015), it is conceivable that the stability
of the GATA1 protein, but not Gata1 mRNA, is reduced in
Tg6 MPP, an effect that might eventually also be reflected
in the overall increased expression of erythroid genes.
KLF1 is also an important and tight regulator of erythroid
lineage commitment that stimulates the expression of
the EPO-R in erythroid progenitors, while inhibiting the
thrombopoietin receptor (TPO-R or MPL [Shah et al.,
2015]). Tg6 HSCs indeed display almost 2-fold higher
Epo-R and lower Mpl expression, which resembles an
erythroid-commitment model similar to megakaryocyte
erythrocyte progenitors (Pre-MgE). Moreover, mass cytom-
etry experiments revealed no differential activation of
EPO/EPO-R signaling pathways in the HSC/MPP/Pre-MgE
fractions of adult Tg6 mice versus WT littermates.
Although one study has demonstrated a functional
EPO-R on HSCs in vitro (Shiozawa et al., 2010), another
report demonstrated no detectable EPO-R expression on
non-erythroid hematopoietic progenitors using in vivo
lineage tracing studies (Singbrant et al., 2011). Therefore,
it is possible that specific but divergent fate changes in
Tg6 HSCs and MPPs are indirectly induced by EPO-trig-
gered erythroid progenitors or through stromal cells in
the BM as suggested previously (Lodish et al., 2010). In
this respect, we recently showed an effect of chronic EPO
exposure on the bone niche, as Tg6 mice revealed signifi-
cant reduction of bone volume related to diminished oste-
oblast and increased osteoclast activity (Hiram-Bab et al.,
2015; Rauner et al., 2016). Endothelial cells are also BM
niche cells containing a functional EPO-R (Trincavelli
et al., 2013). Previously, it was shown that AKT1-activated
BM endothelial cells display a distinct transcription factor
and cytokine profile that can support functional HSCs
under severe stress conditions (Poulos et al., 2015). Further-
more, in the colony assays using methylcellulose-contain-
ing medium without additional EPO, Tg6 HSCs preferen-
tially differentiate into BFUe progenitors. The same cells
also produce more erythrocytes up to 4 weeks after trans-
plantation into WT mice. These results show that even
preceding chronic exposure to high EPO leads to erythroid
fate decision in HSCs, suggesting EPO-induced epigenetic
changes. Further research is therefore required to unravel
the (in)direct and/or temporal role of EPO/EPO-R on the
bone/BM.
Although acute exposure to EPO decreases the Pre-GM
signature in the HSC/MPP compartment (Grover et al.,
2014), our comprehensive GSEA data analysis clearly
linked Tg6 MPPs, but not HSCs, to the myeloid network,
implying the existence of two clearly distinct signatures
that apparently limited the contribution of MPPs to the
response to the enhanced RBC demand. Despite the defin-
itive innate immune signature, our observations from
colony assays and Tg6 MPP transplantation experiments
clearly show hampered differentiation into more mature
myeloid progenitors. In addition, CSF1R+-Tg6 MPPs ex-
pressed significantly less GATA1, indicating the existence
of distinct erythroid and myeloid Tg6 MPP fractions.
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To conclude, we show that EPO can induce transcrip-
tional rewiring, which leads to continuous and chronic
overproduction of erythroid progenitors largely driven by
HSCs rather than MPPs. Moreover, our data show that a
stepwise progression through specific differentiation stages
is probably not essential for HSC lineage commitment, as
also suggested previously (Yamamoto et al., 2013). Tg6
MPPs display two cell signatures with different functional-
ities that also result in hamperedmyeloid progenitor differ-
entiation and the absence of erythroid progenitor overpro-
duction. Our findings not only provide insights into the
role of HSCs during erythroid stress, but may also have
implications for other hematopoietic-related chronic disor-
ders and long-term clinical therapies, including the appli-
cation of EPO-stimulating agents.
EXPERIMENTAL PROCEDURES
Mice
All transgenic mice (Vogel and Gassmann, 2011) and their WT
littermates were bred and maintained in our animal facility with
ad libitum water and food. C57BL/6 (B6), B6.SJL-PtprcaPep3b/
BoyJ (B6.SJL), and Ubc:GFPmice were purchased from the Jackson
Laboratory. Experiments were performed with male and female
mice (aged 3–5 months), and experimental procedures were
approved by the local ethics committee.
Flow Cytometry and Sorting
Flow cytometry, cell sorting, and cell-cycle analyses were
performed as described previously (Singh et al., 2013).
Transplantation
HSCs or MPPs were isolated from Ubc:GFP-Tg6 and Ubc:GFP WT
littermates. A total of 5,000 Lin cKIT+ SCA-1+ CD48+ CD150–
(MPP) from WT-Ubc:GFP and littermate Tg6-Ubc:GFP or 300
cKIT+ SCA-1+ CD48– CD150+ CD34– (HSC) were competitively
transplanted together with non-fractionated 5 3 105 B6.SJL
(CD45.1) BM cells into lethally irradiated (9 Gy) congenic WT
recipients. Peripheral blood was analyzed on a BD fluorescence-
activated cell sorting Canto or on a Sysmex.
Telomere Lengths
Sorted 53 104 MPPs were fixed with 70% Formamid, stained with
PNA Cy3 probe and incubated for 10 min at 82C. Consequent
incubation overnight at room temperature (RT) after which
samples were washed twice with 70% Formamid. DAPI solution
was used to discriminate between G0/G1 and S/G2/M phases of
the cell cycle. Samples were analyzed on LSRII and MFI for cells
in G0/G1 phases was estimated.
Differential Gene Expression Analysis
Complete cDNA(pre-amplified for allHSCsamples)wassynthesized
with the SMARTerUltraHVKit (Clontech). After ultrasonic shearing
of the amplified cDNA (Covaris S2) samples were subjected to stan-
dard Illumina fragment library preparation using the NEBNext
chemistries (New England Biolabs). Libraries were equimolarly
pooled and sequenced on an Illumina HiSeq 2500, resulting in ca.
32–43million single-end readsper library. After sequencing, FastQC
(http://www.bioinformatics.babraham.ac.uk/) was used to perform
abasic quality control on the sequencingdata.As anadditional con-
trol, library diversity was assessed by redundancy investigation in
the reads. Next, the reads were aligned with BWA (v.0.7.8) against
the mouse reference (mm10) and an exon-exon junction library of
120nucleotides, whichwas created according to the Ensembl anno-
tation version 69. The uniquely aligned reads were counted with
featureCounts (v.1.4.4) and the same Ensembl annotation. Normal-
izationof the rawreadcountsbasedonthe library sizeand testing for
differential expression between the two conditions was performed
with theDESeq2 (v.1.4.0) R package.Geneswith an adjusted p value
of less than 0.1 were considered as differentially expressed for com-
parison. Differential gene expression analysis was performed using
the DEseq2 R package to compare gene expression levels between
Tg6 and WT mice for both HSC and MPP cell types. DEseq gave
6,629 significantly DEGs when comparing Tg and WT mice for
HSC cells and 3,801 DEGs for MPP cells (p-adjusted value < 0.1).
To compareDEGs between cell typesweperformed a simple overlap
analysis (using Ensembl Gene IDs) to identify common and unique
DEG, and performed a more fine-grained comparison by splitting
DEGs into up and downregulated genes for each cell type.
GO Enrichment Analysis
Significantly differentially upregulated genes (p-adjusted value <
0.1, fold-change R 2) from both HSCs and MPPs (710 genes
HSC, 248 genes MPP) were mapped to Entrez Gene and analyzed
using the clusterProfiler R package for GO term enrichment
(enrichGO function, GO:BP ontology, p value cut-off = 0.1, BH
adjusted p value cutoff 0.00001 (Yu et al., 2012). A selection of
the GO terms represented in Figures 3B and 4A, include genes as
shown in (Tables S1 and S2).
Gene Set Enrichment Analysis
Gene set enrichment analysis (GSEA) was used to compare gene
lists from other cell types, namely Pre-MgE, MkP, Pre-GM, CLP
(Sanjuan-Pla et al., 2013), CFUe up- and downregulated genes
from (Li et al., 2014). GSEA analysis was performed using GSEA
software from the Broad Institute (Mootha et al., 2003; Subrama-
nian et al., 2005). HSC and MPP were ranked by log2 fold-change,
the two lists were imported, lists pre-ranked, and compared against
gene lists from cell types stated above.
Overlap Analysis
Comparisons between Pre-GM and DEGs from HSCs and MPPs
were performed (overlap diagram based on gene symbols) along
with a similar comparison for CFUe Down, HSC, and MPP
DEGs. Genes unique to Pre-GM and MPP gene lists were then
input into the Cytoscape plugin CLUEGO for further characteriza-
tion, and identical analysis was also performed on genes unique
to CFUe Down and MPP sets. Plots to compare log2 fold-change
for genes unique to Pre-GM and HSC, and Pre-GM and
MPP were created, along with a similar analysis for CFUe Down
genes.
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Mass Cytometry
BM cells from two femurs and two tibia were used for mass cytom-
etry obtained by crushing in PBS and immediately fixed with
Maxpar Fix I Buffer (Fluidigm) for 30 min at room temperature.
For surface staining, cells were incubated with antibodies labeled
with Metal-tags (CD150-167ER [cat. no. 3167004B], CD48-156Gd
[cat. no. 3156012B], CD117-173Yb [cat. no. 3143001B], SCA-1
169Tm[cat. no. 3169015B],CD41-143Nd [cat. no. 3143009B]; [Flu-
idigm] and CD105PE [cat. no. 12-1051-82]; [eBioscience], and for
the secondary step anti-phycoerythrin [MaxPar Ready] labeled
with 160Gd [cat. no. 408105]; [Biolegend]). Next, cells were fixed
and stained with specificmetal tags antibodies against phosphory-
lated proteins (pAKT (S473)-152Sm [cat. no. 3152005A], pSTAT5
(Y694) [cat. no. 3150005A], pERK1/2 (T202/Y204)-171Yb [cat. no.
3171010A]; [Fluidigm]). Cells were incubated overnight inMaxPar
FixandPermBuffer (Fluidigm)with1:10,000dilutionCell-ID Inter-
calator-Ir (Fluidigm), and analyzed on CyTOF2.
Immunocytochemistry
Different cell populations were sorted directly on to slides, dried at
RT, fixed, incubatedwithGATA1 Alexa Fluor 647 antibody (cat. no.
sc-265AF647) (SantaCruz Biotechnology), and analyzed on a Leica
TCS SP5 confocal microscope.
Semi-solid Colony-Forming Assay
One hundred HSCs and 500 MPPs were sorted and cultivated in
duplicate in methylcellulose-containing medium (MethoCult
M3434). Colonies were counted microscopically at day 7.
Statistics
Data are presented as mean ± SEM. Significance was calculated
using the Mann-Whitney U test. All statistical analysis was
performed using GraphPad Prism v.6.03 (GraphPad, La Jolla,
CA). Significance was set at p < 0.05. n in the figure legends always
denotes individual mice.
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